Cargando…
The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease
We investigated comparison according to reflux esophagitis and non-erosive reflux disease about “daily” symptom improvement for proton pump inhibitor treatment. We enrolled 57 reflux esophagitis and 90 non-erosive reflux disease patients. They took rabeprazole 10 mg/day for 28 days and completed “da...
Autores principales: | Shida, Hiroshi, Sakai, Yuzo, Hamada, Hiroyuki, Takayama, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541423/ https://www.ncbi.nlm.nih.gov/pubmed/23341702 http://dx.doi.org/10.3164/jcbn.12-69 |
Ejemplares similares
-
Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018) -
Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019) -
Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients
por: Deppe, Herbert, et al.
Publicado: (2015) -
Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Wang, Yan, et al.
Publicado: (2021) -
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
por: Mermelstein, Joseph, et al.
Publicado: (2016)